FDA Inspection 1256775 — Alexandre Khuskivadze MD, PhD
The FDA completed an inspection of Alexandre Khuskivadze MD, PhD on November 22, 2024 in Tbilisi. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 22, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tbilisi (Georgia)
Additional Details
Clinical Investigator (CI)